Cargando…
Review of cancer treatment with immune checkpoint inhibitors: Current concepts, expectations, limitations and pitfalls
Immunotherapy by checkpoint inhibition is about to profoundly change cancer therapy. The number of indications are growing at an unprecedented speed. Clinical studies have demonstrated efficacy in a variety of solid tumors and in hematologic malignancies, although some clinical trials have produced...
Autores principales: | Thallinger, Christiane, Füreder, Thorsten, Preusser, Matthias, Heller, Gerwin, Müllauer, Leonhard, Höller, Christoph, Prosch, Helmut, Frank, Natalija, Swierzewski, Rafal, Berger, Walter, Jäger, Ulrich, Zielinski, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816095/ https://www.ncbi.nlm.nih.gov/pubmed/29098404 http://dx.doi.org/10.1007/s00508-017-1285-9 |
Ejemplares similares
-
Signet Ring Cell Carcinoma of the Lung: A Diagnostic Pitfall in Pregnancy
por: Danzinger, Sabine, et al.
Publicado: (2019) -
CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
por: Preusser, Matthias, et al.
Publicado: (2017) -
Cancer immune cycle: a video introduction to the interaction between cancer and the immune system
por: Preusser, Matthias, et al.
Publicado: (2016) -
Educational video: the role of PD-L1 in the local tumour microenvironment
por: Preusser, Matthias, et al.
Publicado: (2017) -
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
por: Starzer, Angelika Martina, et al.
Publicado: (2022)